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I. Introduction 
Under physiological conditions, both ATP and 
ADP exist as a rapidly eqLiiIib~ting mixture of Mg2’- 
nucleotide chelates [I 1, but ATP- and/or ADP- 
utiiizing enzymes are pres~lmably specific for a 
particular metal-nuclcotide coordination isomer 
[X-4]. In order to determine the metal-nucleotide 
chelate for which various enzymes are specific, two 
fruitful approaches have been developed. The first 
method, pioneered by Cleland and coworkers [I ,3], 
involves the use of exchange-inert metal-nucleotide 
complexes; e.g., the interaction of yeast hexokinase 
with the coordination isomers of Co(NH3)&TP and 
CrADP, respectively, showed that the substrate of 
this enzyme is the /3,-r-bidentate metal-ATP chelate 
[5] and that the product is the/%monodentate metal- 
ADPchelate [3], (See also [6-81 for other examples.) 
The second method for determining whether the 
meta ion is liganded to a given phosphate moiety 
involves the use of nucleoside phosphorothioates 
1491. Thus, Jaffe and Cohn [ IO,1 I] have investigated 
the substrate specificity of yeast hexokinase for the 
diastereomers of ATPcvS and ATP@ as a function of 
metal cation and have concluded that the metal is 
liganded to the /&phosphorus but not to the cx-phos- 
phorus of enzyme-bound ATP. (See [12-l 41 for 
other examples.) 
Myosin, the major protein constituent of muscle, 
catalyzes the hydrolysis of ATP to ADP [15-171. 
Abbreviations: ATPaS and ATP@, adenosine S’-O-(l-thiotri- 
phosphate) and 5’-O-(2-thiotriphosphate), respectively; 
ADPoS, A and 8, the two diastereomers of adenosine 
5’-o-(1-thiodiphosphate); ADPPS, 5’.G(24hiodiphosphate); 
ATPase, adenosine triphosphatase 
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The presence of a divalent metal ion such as Ca2+, 
Mn2*, Co2+, or Mg2” { 1 S] or a monovalent ion such 
as NH4+ , K* or Rb* [ 191 is necessary for activity. 
~agshaw and Trenthal~ 1201 have shown that the 
metal ion is associated with ATP in the myosin- 
substrate complex and that it is released as a complex 
with ADP. In addition, it has been shown that the 
metal, when complexed to ADP at the active site, is 
highly sequestered from bulk solvent 12 1,221. 
Rarnirez et al. [?3] have postulated that myosin is 
specific for the A ~~-bidentate--tlletal &elate of 
ATP whereas Goody and Hofmann [24] have con- 
cluded that the substrate is the A esu tridentate 
isomer. Preliminary evidence from this laboratory 
[ZS] indicates that the metal is not Iiganded to the 
&phosphorus of the substrate. Iiere we investigate the 
inhibition of myosin ATPase by pl~osphorothioate 
analogs and Cr3’ complexes of ADP in order to deter- 
mine the structure of the metal-ADP product. Results 
indicate that ADP is formed as the ~-l~~onod~ntate 
metal c&elate. 
2. Materials and methods 
ATP and ADP were purchased from Pharma- 
Waidorf, [y-32P]ATP was obtained from ~ersham 
Buchier, and ADPpS was supplied by Boehringer 
Marlnheim. Rabbit skeletal myosin was isolated and 
quantitated as in 1261. 
The two diastereomers of ADP& were prepared 
from the corresponding ATPolS isomers [27] by diges- 
tion with myosin at room temperature in a solution 
containing -5 mM ATP&, 2.5 mM Tris-HCI, (pH S.O), 
0.1 M KCl, 10 mM CaC12, and 1 mg enzyme/ml. The 
reaction mixture was ~hromatographed at 4’C 
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through a DEAE-Sephadex A-25 column using a 
linear gradient of 0.1-l .O M triethylammonium 
bicarbonate (pH 7). 
The&monodentate chelate of CrADP was prepared 
by the procedure in 13,281 by heating a solution 
20 mM each in CrCle and NazHADP for 1 min at 
80°C. The a@-bidentate isomers of CrADP were 
prepared by the method used to make the mono- 
dentate isomer, except that the heating time was 
increased from l-10 min [ZS]. The CrADP isomers 
were characterized by their inI~ibitior1 or lack there- 
of against yeast hexokinase [3,28]. 
Ail myosin assay solutions contained in 2 ml: 
1 JQ enzyme/ml; 25 mM irnidazolium-HCl, (pH 7.0 
or 8.0); 0.5 M NaCl; and either 5 mM MgCl2 or 
1 mM CoC12. Enzymatic hydrolysis of ATP was mea- 
sured as in 126,291. 
3. Results and discussion 
As noted in [29], the steady-state kinetics of 
myosin is biphasic, showing substrate activation at 
high substrate concentrations. In order to investigate 
the inhibition of myosin ATPase at the active site by 
ADP and its analogs, it was necessary to work at 
<OS PM substrate and <IO0 PM inhibitor, (At high 
substrate and inhibitor ~oncelltrations, ADP inhibits 
myosin R’-ATPase in a predominantly noncompeti- 
tive manner [data not shown] with k’i = 20 rnM). 
Fig.1 shows some representative data for the inhibition 
of myosin Mg2+-ATPase by various ADP phosphoro- 
thioate analogs. Similar data were obtained for 
myosin’s Co2’-ATPase activity. Table 1 summarizes 
the kinetic parameters which have been obtained, 
(Myosin showed no ATPase activity in the presence 
of Ni’+, Zn2+, or Cd’*.) 
Both diastereomers of ADPaS are good i~~Ilibitors 
of myosin ATPase, with the Ki value for the B isomer 
being about twice that for the A isomer regardless of 
whether the metal ion is Mg” or Co”; i.e., myosin’s 
inhibitor selectivity with respect to the two dia- 
stereomers of ADPolS appears to be independent of 
the metal ion. This may be taken as prima facie 
evidence that the metal does not coordinate to the 
a-phosphorus in the enzyme--ADP complex [4,9]. 
In order to provide conclusive evidence for this, lack 
of reversal with a metal ion such as Cd2’, which 
strongly prefers chelationto sulfur, should be observed 
[ 131. However, since myosin is not active in the 
V/S ~ml/min/mg) 
Fig.1 _ Eadie-Hofstee plot of myosin Mg”-ATPase (o- -o) and 
its inhibition by IO &I ADP (*- -01, ADPpS (n- -o>, ADPaS, A 
(A- -n). and ADI’&, B (v- -v). p&I 8.0; other conditions arc as 
in section 2. 
presence of Cd2’, an alternative approach was chosen 
to identify further the nature of the enzyme-product 
complex. 
The ~-nlonodellt~~te and ~~-bidentate complexes 
of CrADP were prepared and tested for their inhibitor 
activity against myosin Mg”-ATPase at pH 7.0. The 
following values were obtained: Ki @-CrADP) = 3 i_tM 
and K, ((r&CrADP) = 10 1 PM (for ATP, K, = 0.022 I.IM 
and Vn,, = 14 nmol . min-‘. mg-I). If it is assumed 
that the (r@-CrADP consisted of a 50:50 mixture of 
the LS and A diastereomers and that only one of the 
isomers is an inhibitor of myosin. then the p-mono- 
dentate chelate is still -20-fold better inhibitor than 
Table 1 
InI~ibition constants for ADP and its phospl~orothioate 
analogs” 
Mg2’-ATPasc Co2’-ATPase 
li max, nmol . mid . mg-’ 20 26 
Km, !JM 0.022 0.28 
Ki (ADP), rhl 0.39 1.1 
Ki (ADPcxSTA), I.IM 1.6 5 
Ki (ADP~YSJ~), PM 3.5 9 
Ki (ADPPS), FM 0.65 14 
- - 
a Conditions are as in fig.1 
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either bidentate &elate. This result therefore con- 
firms that the metal--ADP product exists as the 
~-rno~~odentat~ chelate. (Compare with the results in 
[XI], where no binding of a&bidentate CrADP to 
myosin subfragment-f was observed.) 
Dunaway-Mariano and Cleland [3] have classified 
kinases into two groups: those which bind ATP as a 
mctai-~,~-bidentate complex (e.g., creatine kinase) 
and those wherein the ~-~tl~)n~~dentate me al-ADP 
complex is the product (e.g., yeast hexokinase). 
These authors found that most of the kinases so far 
studied belong in the former category whereas the 
few which belong in the latter category catalyze 
essentially irreversible reactions. Our results indicate 
that myosin belongs in the latter category, thus con- 
firming and extending the generaiizatio~ that enzymes 
which are specific for the ~-lnonodentate metal...-ADP 
&late catalyze irreversible reactions. 
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